SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-102908
Filing Date
2023-09-22
Accepted
2023-09-22 09:38:12
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2326474d1_s3.htm S-3 192934
2 GRAPHIC tm2326474d1_s3img001.jpg GRAPHIC 5636
3 EXHIBIT 5.1 tm2326474d1_ex5-1.htm EX-5.1 6399
4 EXHIBIT 23.1 tm2326474d1_ex23-1.htm EX-23.1 2385
5 EX-FILING FEES tm2326474d1_ex-filingfees.htm EX-FILING FEES 10569
6 GRAPHIC tm2326474d1_ex5-1img001.jpg GRAPHIC 7427
  Complete submission text file 0001104659-23-102908.txt   231783
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-274634 | Film No.: 231270385
SIC: 2834 Pharmaceutical Preparations